
BullFrog AI Holdings, Inc. — Investor Relations & Filings
BullFrog AI Holdings, Inc. is a technology-enabled drug development company that applies artificial intelligence (AI) and machine learning (ML) to advance new therapeutics. The company utilizes a proprietary suite of AI models, featuring causal AI and graph-based analytics, to analyze complex biological data and model disease systems. The core focus is on identifying and validating novel drug targets to improve the efficiency and success rate of the drug development process. By enhancing the precision of target selection, BullFrog AI aims to accelerate research and development timelines, reduce costs, and increase the probability of clinical success for life-saving medicines.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - BullFrog AI Holdings, Inc. (0001829247) (Filer) | 2026-04-22 | English | |
| 8-K - BullFrog AI Holdings, Inc. (0001829247) (Filer) | 2026-04-21 | English | |
| 424B5 - BullFrog AI Holdings, Inc. (0001829247) (Filer) | 2026-04-01 | English | |
| 8-K - BullFrog AI Holdings, Inc. (0001829247) (Filer) | 2026-04-01 | English | |
| 10-K - BullFrog AI Holdings, Inc. (0001829247) (Filer) | 2026-03-19 | English | |
| 8-K - BULLFROG AI HOLDINGS, INC. (0001829247) (Filer) | 2026-02-21 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
7 filings
| |||||
| 35255452 | 8-K - BullFrog AI Holdings, Inc. (0001829247) (Filer) | 2026-04-22 | English | ||
| 34939346 | 8-K - BullFrog AI Holdings, Inc. (0001829247) (Filer) | 2026-04-21 | English | ||
| 33150088 | 424B5 - BullFrog AI Holdings, Inc. (0001829247) (Filer) | 2026-04-01 | English | ||
| 33149393 | 8-K - BullFrog AI Holdings, Inc. (0001829247) (Filer) | 2026-04-01 | English | ||
| 32989585 | 10-K - BullFrog AI Holdings, Inc. (0001829247) (Filer) | 2026-03-19 | English | ||
| 32899317 | 8-K - BULLFROG AI HOLDINGS, INC. (0001829247) (Filer) | 2026-02-21 | English | ||
| 31952147 | 8-K Filing | 2026-02-17 | English | ||
|
2025
8 filings
| |||||
| 13328784 | 8-K | 2025-12-30 | English | ||
| 13328785 | 424B3 | 2025-12-01 | English | ||
| 13328787 | Regulatory Filings 2025 | 2025-11-26 | English | ||
| 13328786 | 10-Q | 2025-11-14 | English | ||
| 13328788 | 424B5 | 2025-11-07 | English | ||
| 13328789 | 8-K | 2025-10-24 | English | ||
| 13328790 | S-1 | 2025-10-10 | English | ||
| 13328791 | 8-K | 2025-10-09 | English | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova (Taiwan) Corporation
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
BullFrog AI Holdings, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35102/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35102 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35102 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35102 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35102}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for BullFrog AI Holdings, Inc. (id: 35102)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.